China's COVID-19 vaccine trial shows promising results -- The Lancet

Source:Xinhua Published: 2020/5/22 22:45:15

Photo: Xinhua

China's COVID-19 vaccine trial, the first such vaccine to reach phase 1 clinical trial, has been found to be safe, well-tolerated, and able to generate an immune response against SARS-COV-2 in humans, according to a study published online on Friday by medical journal The Lancet.

Posted in: SOCIETY

blog comments powered by Disqus